Exclusive: Intercept Pharmaceuticals explores potential sale - sources

(Reuters) - Intercept Pharmaceuticals Inc , a U.S. biotechnology company focused on advanced treatments for liver disease, is exploring a potential sale after receiving interest from other companies,...